The landscape of dementia prognosis has evolved dramatically with the arrival of sophisticated biomarkers, which include amyloid PET scans, tau imaging, and blood-based exams which will detect Alzheimer's pathology many years ahead of symptoms emerge. Although these technological advancements represent exceptional development in being familiar with